Abbott Laboratories stock rises Friday, still underperforms market
Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...
Abbott Laboratories closes flat after six sessions of gains
Abbott Laboratories (ABT) sees mixed momentum as shares dip after gains. Analysts highlight strong demand, low debt, and ...
2ABT : What Does the Market Think About Abbott Laboratories?
Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...
With 79% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners
Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...
Litigators of the Week: In Class Action Trial Over PediaSure Label Claims, a Complete Defense Verdict for Abbott
Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Laboratories Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$42.0b (up 4.6% from FY ...
pharmaphorum1d
A history of Abbott and AbbVie
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...
Concussion Market Projected To Witness Substantial Growth, 2025-2032: Abbott Laboratories, Brainscope Company Inc
Concussion Market is estimated to be valued at USD 7.24 Bn in 2025 and is expected to reach USD 10.96 Bn by 2032, ex ...